Skip to main content

Table 1 Characteristics of the CLL patients used for flow cytometric analysis

From: Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLL

# of patients7
Age [years]57.1 (mean)
52 (median)
Sex5/7 male
2/7 female
Prior therapies7/7 no prior treatment
Binet stage7/7 A
0/7 B
0/7 C
IGHV status6/7 mutated
1/7 unmutated
Genetics (FISH)1/7 Trisomy 12
5/7 del(13q)
1/7 no aberration
TP53 mutation status4/7 WT
3/7 not tested